2.29
+0.08(+3.62%)
Currency In USD
| Previous Close | 2.21 |
| Open | 2.19 |
| Day High | 2.36 |
| Day Low | 2.19 |
| 52-Week High | 12.45 |
| 52-Week Low | 1.26 |
| Volume | 53,898 |
| Average Volume | 4.12M |
| Market Cap | 3.42M |
| PE | 0 |
| EPS | 499.26 |
| Moving Average 50 Days | 1.87 |
| Moving Average 200 Days | 2.38 |
| Change | 0.08 |
If you invested $1000 in Bluejay Diagnostics, Inc. (BJDX) since IPO date, it would be worth $0.05 as of October 30, 2025 at a share price of $2.29. Whereas If you bought $1000 worth of Bluejay Diagnostics, Inc. (BJDX) shares 3 years ago, it would be worth $0.35 as of October 30, 2025 at a share price of $2.29.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 10, 2025 9:16 PM GMT
ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced the closing of its previously
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 09, 2025 7:15 PM GMT
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into defin
Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform
GlobeNewswire Inc.
Oct 09, 2025 10:30 AM GMT
ACTON, Mass. and YAMANASHI, Japan, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient testing solutions for critical care, today announced t